Two approaches were used to demonstrate proteolysis of reovirus in the intestine of the neonatal mouse. The first approach utilized peroral inoculation of radiolabeled virus into neonatal mice; the intestinal washings were havested at 0 to 30 min postinoculation. The virus recovered from the intestinal washings was electrophoresed in polyacrylamide to determine whether proteolytic digestion of viral proteins had occurred. Complete loss of sigma 3 and generation of the ,ulc cleavage product delta demonstrated that digestion occurred within 10 to 30 min after the inoculation, resulting in the rapid generation of intermediate subviral particles (ISVPs). The products formed resembled those seen when the virus is digested in vitro with chymotrypsin. The second approach took advantage of the fact that ISVPs grow in cells treated with NH4C1, whereas intact virus does not grow under these conditions (L.
Initiation of a viral infection is often dependent on cleavage of one or more viral proteins by host or exogenous proteases. Studies of viral infectivity in cell culture have elucidated the mechanism by which cleavage of the influenza virus hemagglutinin renders the virus infectious (reviewed in reference 16) , and the importance of proteolysis has also been established by studies of nonenveloped viruses, notably the rotaviruses (1) . Cleavage of viral proteins in the animal host has been explored indirectly by the use of protease inhibitors (1, 15, 18, 19) or by examination of fluids extracted from a variety of tissues for the ability to effect the critical cleavage of the virus in question (3) . The intestine is an important site of viral entry into the animal host and by virtue of its high content of proteases can be expected to be a site in which digestion of virus occurs. However, a direct demonstration of proteolysis at this or any other site in the intact host has been lacking. Nor has it been possible to monitor the course of proteolysis throughout the life cycle of the virus in the host.
Reoviruses offer the possibility for investigating the interaction of virus with proteases in the animal host because of the ease with which the proteolytically digested form of the virus can be distinguished from the intact virus. In vitro, proteolytic digestion of reovirus with chymotrypsin or trypsin under defined conditions results in the generation of fully infectious particles, termed intermediate subviral particles (ISVPs), which are distinguished from intact virus by the removal of the outer capsid protein sigma 3 and by the generation of the cleavage product delta from the outer capsid protein ,ulc (7) . Alternatively, the end product of an in vitro digestion of reovirus with chymotrypsin or trypsin may be cores, which have undergone proteolysis beyond the ISVP stage, having lost delta and sigma 1 in addition to sigma 3 . Whereas ISVPs have retained full infectivity (7), cores are no longer infectious. Whether in vitro digestion with chymotrypsin or trypsin yields ISVPs or cores depends on the concentrations of virus and enzyme and on the salt conditions used in the digestion.
Recently, Sturzenbecker et al. (13) demonstrated that ISVPs grow in cells which have been treated with NH4Cl, whereas intact virus does not grow under these conditions. Therefore, assay of a given virus sample for its ability to grow in NH4Cl-treated cells represented a means of ascertaining whether that sample contains ISVPs. Such an approach is applicable to any in vitro-or in vivo-generated sample. In this study, we have demonstrated that reovirus serotype 1 is proteolytically digested to ISVPs in the lumen of the neonatal mouse intestine. In addition, we have monitored the physical changes the virus undergoes during the early events of infection in the intestinal lumen and in the intestinal tissue.
MATERIALS AND METHODS
Cells and virus. Mouse L cells were propagated in suspension in Joklik minimal essential medium as has been described previously (9) . L cell monolayers were used to plaque virus and for subsequent propagation of virus. Reovirus serotype 1 Lang was a standard laboratory stock.
For all experiments, purified reovirus serotype 1 Lang was used. The method of labeling with [35S]methionine and purifying virus has been described previously (13) . For the NH4Cl experiments, unlabeled, purified virus was diluted to a concentration of 108 PFU/ml. The viral suspension (100 ,ul) was inoculated into each animal. All experiments were done with virus that had been purified less than 2 months previously. The particle/PFU ratios of the purified virus used in PROTEOLYSIS OF REOVIRUS IN VIVO 4677 inoculations was approximately 200:1. The experiments using radiolabeled virus allowed us to determine that recovery of the radiolabeled material from the lumen of the small intestine of animals was between 7 and 20% of the input inoculum (data not shown).
Animal experiments. Pregnant NIH Swiss mice were obtained from the National Cancer Institute, Frederick, Md. Neonatal mice were inoculated 2 days after birth by intragastric intubation (12) . At specified times after inoculation, mice were sacrificed by cervical dislocation. The abdomen was opened, and the intestine was dissected from duodenum to just below the cecum. The lumen samples consisted of the intestinal contents that were harvested by flushing with a 1-ml syringe filled with dialysis buffer (150 mM NaCl, 10 mM Tris [pH 6.8], 10 mM MgCl2) to which had been added 10 ,ul of the following stock solutions of protease inhibitors: chymostatin (0.33 mg/ml), soybean trypsin inhibitor (1 mg/ml), aprotinin (3 mg/ml) and phenylmethylsulfonyl fluoride (100 mM). The tissue remaining after the intestine was washed twice with 1 ml of the above solution was placed in a vial containing 1 ml of dialysis buffer with protease inhibitors. The samples were frozen at -70°C. The addition of protease inhibitors to the solution used to harvest the samples ensured that the ISVPs observed had been formed in the animal before the sample was harvested and that they were not formed artifactually after the organs were harvested.
Virus controls were made as follows. Purified virus (107 PFU) was added to uninfected tissue and washed after these were harvested from the animal as described above. These virus control samples were then treated exactly as the experimental samples. In vitro-generated ISVPs were made before each assay. ISVP assay. 1 Lang, the animals were killed at the times specified. The gastrointestinal tract was removed, and the contents of the lumen were harvested by flushing the intestine with 2 ml of dialysis buffer containing protease inhibitors. Cellular debris was removed by centrifuging the samples twice for 5 min each in a microcentrifuge. The samples were then centrifuged for 45 min in an SW50.1 rotor at 45,000 rpm to pellet the virus. The pellet was suspended in Laemmli sample buffer. Immediately before electrophoresis, the samples were boiled for 2 min. Samples were electrophoresed in a Trisglycine-buffered, 5 to 20% polyacrylamide gel. One experiment included a virus control and the 0-to 30-min time points; a separate experiment examined two animal samples for the 2-h time point and included controls of both intact virus and ISVPs generated in vitro with chymotrypsin. It is important to note that in this and subsequent experiments the zero time point represented an animal whose intestinal contents were harvested as rapidly as possible after inoculation. Given the time needed to sacrifice an animal and harvest the luminal contents, some digestion had occurred at the zero time point in this and subsequent experiments.
directly whether the input viral inoculum was interacting with proteases, thereby being converted to ISVPs or cores in the intestinal lumen, neonatal mice were inoculated perorally with radiolabeled reovirus serotype 1. At specified times postinoculation, the animals were killed, the gastrointestinal tract was removed surgically, and the contents of the lumen were harvested by flushing the intestine with 1 ml of dialysis buffer. The samples were centrifuged to pellet the virus. Gel electrophoresis of the recovered virus made it clear that digestion of the virus occurred and was extremely rapid (Fig. 1 ). As expected, there was considerable variability in the amount of virus recovered from the intestinal lumen. This animal-to-animal variability in the recovery of samples (for example the 30-min versus the 2-h samples in Fig. 1 intensity of the lambda and sigma 1 proteins). At 2 h postinoculation, ISVPs were still observed ( Fig. 1) , demonstrating that ISVPs were resistant to further digestion in the gastrointestinal tract. In Fig. 1 Since we were unable to harvest virus from the intestinal lumen without seeing some digestion of sigma 3, we asked whether proteolysis occurred in the stomach before the virus reached the gastrointestinal tract. Radiolabeled virus harvested from stomach contents showed no significant proteolytic digestion, providing strong evidence that digestion occurred in the small intestine (Fig. 2) .
Characterization of an assay to detect ISVPs by using
NH4Cl. Since we detected ISVPs by using radiolabeled virus, we wanted to develop an assay that would allow us to detect ISVPs under more general conditions and in particular under conditions in which it was not necessary to use the high-dose inoculum used in the experiments with radiolabeled virus. We took advantage of the fact that intact reoviruses do not grow in cells treated with NH4Cl, whereas ISVPs do grow under those conditions (13) . Thus, assay of a sample for its ability to grow in NH4Cl-treated cells represented a means of determining whether that sample contained ISVPs. Figure 3 describes the design of the ISVP assay, using NH4Cl. Initially, we did three experiments using ISVPs generated in vitro with chymotrypsin to determine whether the ISVP assay was quantitative. (i) A mixing experiment was performed, in which the amounts of virus and ISVPs were varied among samples, but the total amount of infectious material remained constant. The results of this experiment demonstrated that increasing amounts of ISVPs gave increased growth in NH4Cl-treated cells (Fig. 4) exhibited by ISVPs was independent of the multiplicity of infection used to infect the cells (Fig. 5). (iii) Last, we examined controlled proteolytic digestion of virions and showed that populations of particles which were partially digested to ISVPs showed intermediate levels of growth in the presence of NH4Cl (Fig. 6A and B) . The conclusion from these in vitro experiments (Fig. 4, 5, and 6 ) was that the ISVP assay was semiquantitative and that samples generated in vivo which showed intermediate levels of growth contained ISVPs in amounts roughly proportional to the amount of growth that was seen in NH4C1.
Conversion of virus to ISVPs in the gastrointestinal tract and subsequent regeneration of virus. Analysis of tissue and lumen samples recovered between 0 and 30 min postinoculation by using the ISVP assay demonstrated that conversion to ISVPs was complete by 30 min (Fig. 7A) . In the experiments using radiolabeled virus, conversion to ISVPs occurred between 10 and 30 min (Fig. 1) . Thus, the ISVP assay was in general agreement with the direct analysis using radiolabeled virus in showing that the generation of ISVPs in the lumen of the intestine takes place very quickly. In the intestinal tissue, a decrease in the proportion of ISVPs became apparent after 8 h postinoculation (Fig. 7A) . By 10 h postinoculation, ISVPs represented a small fraction of the virus present in tissue, and by 15 h postinoculation ISVPs were no longer detectable in the tissue (Fig. 7A) . Concomitant with the decrease in proportion of ISVPs in the tissue, there was an increase in viral titer of 103 PFU that occurred between 8 and 15 h postinoculation (Fig. 7B) . The increase in viral titer is consistent with the conclusion that the loss in proportion of ISVPs represented viral replication resulting in production of intact virus.
At still later times of infection (24, 48, and 72 h), intact virus continued to predominate in the intestinal tissue (Fig.  7A) . Although the amount of ISVPs in the tissue appeared to increase by 72 h, no clear pattern could be discerned (data not shown) and the apparent increase may have represented experimental variability.
In the intestinal lumen, a decrease in the proportion of ISVPs correlated with the decrease in the proportion of ISVPs in the tissue (Fig. 7A) . However, whereas in the tissue the ISVP level dropped to being undetectable, in the lumen there was always a detectable proportion of ISVPs (Fig. 7A) . The continued presence of ISVPs could therefore indicate continued generation of ISVPs as a result of the continued presence of luminal proteases (Fig. 7A) . (17) , which subsequently are damaged as a result of reovirus replication (15-h panel) (4) . For the purposes of simplification and because of the importance of the M cell as the cell through which the virus penetrates, we have shown a single M cell, with the virus replicating in undefined mononuclear cells lying beneath it. However, note that at this point virus is already spreading beyond the site(s) depicted in our diagram (4 Fig. 1 and 7) indicate that the vast majority of viral particles are converted to ISVPs by 30 min. The initial round of replication is roughly synchronous, i.e., between 8 and 10 h postinoculation the proportion of ISVPs decreases dramatically in tissues as progeny virus forms (Fig. 6A) .
The poliovirus studies of Minor et al. (8) and Roivainen and Hovi (10) In fact, the current results demonstrate that both the lumen and the intestinal tissues contain a preponderance of digested virus (ISVPs) at early times of infection. Moreover, even at late times of infection, the host immune system continues to be exposed to the digested form of the virus present in the intestinal lumen. After a single cycle of replication, both digested and intact virus are found in the host, thus making it clear that at some point the host immune system will be presented with viral antigens exposed on undigested as well as digested virus. These findings thus may have implications for the design of other vaccines that are administered perorally, such as the rotavirus and enteric adenovirus vaccines. Our data (Fig. 7) show that throughout the course of an infection, ISVPs are continually present in the lumen of the intestine. We have illustrated this as occurring via release of virus from the intestinal tissue (Fig. 8) . However, we do not know the exact source of virus and ISVPs that appear in the lumen at late times of infection. Another possible route by which virus may appear in the intestinal lumen at late times of infection is through the bile (11) . Future studies will be needed to clarify the precise sites through which virus enters the lumen of the gastrointestinal tract.
Thus, this study expands on the well-established role of host proteases in virus activation. The importance of exogenous proteases in viral infections of the animal host had been established in other organs by the presence of activating proteases in lung fluids (3) or in the amniotic fluids of chicken embryos (2). Tashiro et al. (14) have demonstrated that Staphylococcus aureus strains may secrete proteases which cleave the influenza virus hemagglutinin, thereby providing one explanation for the increased virulence of influenza virus seen upon cocultivation of bacteria and influenza virus.
The current study has demonstrated directly the role of proteases in the initiation of viral infection in an intact mammalian host and suggests a role for in vivo proteolysis in the context of the viral life cycle in the host. In addition, the development of an ISVP assay can now be extended to other tissues and may serve as a tool to allow us to investigate the interaction of reoviruses and cellular proteases in different tissues of the mammalian host. 
